A Win For Inhibrx Biosciences, Inc.
Fri, Oct 24, 2025 at 07:24 PM
Inhibrx Biosciences, Inc. (INBX:NASDAQ) jumped higher at $57.29, a gain of 102%. On Fri, Oct 24, 2025, INBX:NASDAQ hit a New 2-Week High of $57.29. The stock appeared on our News Catalysts scanner on Fri, Oct 24, 2025 at 09:44 AM in the 'MISCELLANEOUS' category. From Fri, Oct 10, 2025, the stock recorded 70.00% Up Days and 63.64% Green Days
About Inhibrx Biosciences, Inc. (INBX:NASDAQ)
Inhibrx Inc is a clinical-stage biotechnology company focused on developing a pipeline of novel biologic therapeutic candidates.
Top 10 Gainers:
- Wellgistics Health, Inc. (WGRX:NASDAQ), 185.43%
- Inhibrx Biosciences, Inc. (INBX:NASDAQ), 102.01%
- Genenta Science S.p.A. (GNTA:NASDAQ), 91.95%
- MaxsMaking Inc. (MAMK:NASDAQ), 76.92%
- Neuphoria Therapeutics Inc. (NEUP:NASDAQ), 54.07%
- Datavault AI Inc. (DVLT:NASDAQ), 52%
- New Era Energy & Digital Inc Com (NUAI:NASDAQ), 48.35%
- Newegg Commerce, Inc. (NEGG:NASDAQ), 40.85%
- MidWestOne Financial Group, Inc. (MOFG:NASDAQ), 39.37%
- Kuke Music Holding Limited (KUKE:NYSE), 39.18%